BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:14th Annual Clinical Trials Summit 2023\n\n23rd &amp\; 24th Ma
 y 2023\, Hotel Kohinoor Continental\, Mumbai\, India\n\n14th Annual Clini
 cal Trials Summit 2023 will provide a platform to discuss on the futurist
 ic advancements in Clinical Trials and clinical research. This event open
 s discussion of timely topics of mutual theoretical and practical interes
 t for clinical trial investigators who are developing new drugs and biolo
 gics. This ground breaking platform continues the conversation between bu
 siness\, academics\, patient advocacy\, and regulatory agencies to discus
 s new methods and solutions to statistical challenges relevant to the des
 ign and analysis of Clinical Trials collaboratively in the real world. It
  is high time that we look into innovative strategies\, new technologies\
 , effective and quality collaborations to address these issues\, which ca
 n cater to the needs of the patient and the industry.\n\nPlease contact m
 e at E-mail -&nbsp\;kavitha@virtueinsight.co.in&nbsp\; or Call +91 936195
 7193\n\nSPONSORS:\n\nPrincipal Partner:&nbsp\;Clinical Research Network\n
 \nSilver Partner:&nbsp\;Cognizant SIP\, ClinPro Research\, Clinevo Technl
 ogies\, Octalasoft\n\nExhibitors:&nbsp\;Clinevo Technologies\, Medclinica
 \, Ancillare\, ParadigmIT\, CRYOPDP\, Clinion\n\nWe have more sponsorship
  opportunities available for the event\, which gives you an opportunity t
 o speak and create brand awareness.\n\nDELEGATE REGISTRATION:\n\nSuper Ea
 rly Bird Price&nbsp\;(Valid Till 24th March 2023)&nbsp\;–&nbsp\;INR 11\,0
 00 + GST (18%) per delegate\n\nEarly Bird Price&nbsp\;(Valid Till 4th May
  2023)&nbsp\;–&nbsp\;INR 15\,000 + GST (18%) per delegate\n\nStandard Pri
 ce -&nbsp\;INR 18\,000 + GST (18%) per delegate\n\nKEY SPEAKERS: \n\n\nGO
 URI SHANKAR\,&nbsp\;Assistant Drugs Controller\,CDSCO\nRAVI SEKHAR KASIBH
 ATTA\,&nbsp\;Senior Vice President\, Clinical Research\,Lupin\nPRATIK SHA
 H\,&nbsp\;VP - Medical Affairs\,Bharat Serums and Vaccines\nSADHNA JOGLEK
 AR\,&nbsp\;Head\, Global Drug Development India\,Novartis\nSUYOG MEHTA\,&
 nbsp\;VP &amp\; Head - Medical Affairs &amp\; Clinical Research\, India &
 amp\; Emerging Markets\,Sun Pharma\nRAHUL GUPTA\,&nbsp\;Senior Vice Presi
 dent\, Regulatory Affairs\,USV\nMANISH SHAH\,&nbsp\;Associate Vice Presid
 ent\,Wockhardt\nYASMIN SHENOY\,&nbsp\;Director-Regulatory Affairs\,Sanofi
 \nVIPIN SETHI\,&nbsp\;Asst Vice President\,Cadila\nVAIBHAV SALVI\,&nbsp\;
 Director and Head – Clinical Study Unit\, India and South East Asia\,Sano
 fi\nSEEMA PAI\,&nbsp\;Director Clinical Site Operations – India Cluster\,
 Pfizer\nRISHI JAIN\,&nbsp\;Director Medical Affairs &amp\; Pharmacovigila
 nce\,AbbVie\nMILIND ANTANI\,&nbsp\;Leader\, Pharma and Healthcare\,Nishit
 h Desai Associates\nPRABHAT SINHA\,&nbsp\;Director Government &amp\; Publ
 ic Affairs\,Boehringer Ingelheim\nPANKAJ GUPTA\,&nbsp\;Chief Scientific O
 fficer\,Novartis\nSANTOSH TAUR\,&nbsp\;Director Medical Affairs - Vaccine
 s &amp\; Digital\,Pfizer\nSHIRAZ KANDAWALLA\,&nbsp\;Associate Director Re
 gulatory Affairs\,Ferring Pharmaceuticals\nLESTTER CRUZ SERRANO\,&nbsp\;H
 ead of Medical Affairs &amp\; Global Site Engagement Lead\,Cognizant SIP\
 nDILIP PAWAR\,&nbsp\;Director and Head Clinical Development and Medical A
 ffairs\,Unichem Laboratories\nMUKESH GORI\,&nbsp\;Associate Director - ES
 P Management PV Strategy &amp\; Operations\,Novartis\nTARANNUM KASHMIRI\,
 &nbsp\;Founder and CEO\, ClinPro ResearchKAVITA LAMROR\, Expert\, Real Wo
 rld Investigator &amp\; RWD Product Owner\,Sanofi\nHITENDRA NATH PANDEY\,
 &nbsp\;Associate Director – Statistics\,Eli Lilly\nSADANAND KULKARNI\,&nb
 sp\;Head- Medical\, Regulatory\, Vigilance &amp\; Quality\,Fresenius Kabi
 \nKEDAR NAYAK\,&nbsp\;Head - Clinical Development\,GSK\nJYOTSNA PATWARDHA
 N\,&nbsp\;Cluster Head Clinical / PV Country Quality Middle East / Africa
  / Turkey / India\, Novartis\nKAMLESH PATEL\,&nbsp\;Head -Medical Affairs
  &amp\; Health Tech\,Lupin\nSWATI BISWAS\,&nbsp\;Head- Global Clinical De
 velopment\,Abbott\nSANKET NEWALE\,&nbsp\;Head Medical Affairs\,Emcure Pha
 rmaceuticals\nKAVITA LAMROR\,&nbsp\;Expert\, Real World Investigator &amp
 \; RWD Product Owner\,Sanofi\nANIKET JOSHI\,&nbsp\;Associate Global Portf
 olio Delivery Director\,Novartis\nHARSHAD KOTHAWADE\,&nbsp\;Head of Regul
 atory Management &amp\; Trade Compliance\,Merck Group\nMAYUR MAYBHATE\,&n
 bsp\;Head Medical Affairs\,Alkem Laboratories\nVAIBHAV AGARWAL\,&nbsp\;He
 ad – Digital\,Wockhardt\nPRITI THAKOR\,&nbsp\;General Medical Affairs Man
 ager\,Johnson&nbsp\;&amp\;&nbsp\;Johnson\nINDRANIL PURKAIT\,&nbsp\;Genera
 l Manager and Head Medical Affairs\,Ipca Laboratories\nASHWANI PANDITA\,&
 nbsp\;GM Quality Management &amp\; Training\, Global Clinical Research Op
 erations\,Glenmark Pharmaceuticals\nRAJ KHIRASARIA\,&nbsp\;Regional Medic
 al Operations Champion Specialty Care Africa and Asia\,Sanofi\nSEERA DILE
 EP RAJU\,&nbsp\;Senior Manager - ML &amp\; AI\,MSD\nVISHWAS SOVANI\,&nbsp
 \;Founder Director\,Pharmawisdom\nSAKHARAM GARALE\,&nbsp\;Founder &amp\; 
 CEO\,RENOVARE Healthcare\n\nPlus more joining soon\n\nKEY THEMES: \n\n\nW
 hy Decentralisation is the future of Clinical Trials?\nChallenges and ris
 ks for launching decentralized trials\nHow to manage a Pandemic/Crisis Ma
 nagement in the Future?\nLessons from Covid-19 pandemic on conducting glo
 bal Clinical Trials\nAdvantages\, challenges\, and limitations of technol
 ogy in Clinical Trials\nCurrent status\, challenges and future outlook of
  RWE and RWD\nCollaborations between CROs and the Pharmaceutical Industry
 \nEnhancing Patient centricity and patient safety\nDesigning quality into
  Clinical Trials to optimise patient recruitment\nImpact of digital trans
 formation - Digitizing Clinical Trials\nData Integrity and Data Managemen
 t\nCreating Effective Outsourcing Partnerships\nRemote clinical research 
 – Risks and chances\nEnd-to-end strategic partnership &amp\; managing com
 munication gap in CROs\nAre the regulations sufficient in Clinical Trials
  ? What needs to be done?\nRegulatory updates for bettering Clinical Tria
 ls\nBe part of a major networking opportunity\n\nWHO SHOULD ATTEND:\n\nCI
 Os\, CEOs\, CDOs\, Vice Presidents\, Presidents\, Heads\, Directors and T
 eam Leaders from the following areas: Clinical Research &amp\; Developmen
 t\, Clinical Research Services\, Clinical Operations\, Clinical Data Mana
 gement\, Clinical IT\, Clinical Trials \, Medical Affairs\, Regulatory Af
 fairs\, Compliance\, Quality control / Assurance/GCP\, Clinical Study Des
 ign\, Safety Surveillance\, Subject Recruitment\, E-Clinical System\n\nGe
 t more from the event\, with a broader scope bringing the whole communica
 tions value chain together. Enjoy and make the best out of our dedicated 
 networking time\, meet the leading international vendors showcasing the p
 roducts of tomorrow in the co-located exhibition. Expand your knowledge o
 f the latest business models and strategies in the high-level conference.
 \n
DTEND:20230524T170000
DTSTAMP:20260512T214259Z
DTSTART:20230523T093000
LOCATION:Kohinoor Continental\, Andheri - Kurla Road\, Konkan Division\, 4
 00059\,
SEQUENCE:0
SUMMARY:14th Annual Clinical Trials Summit 2023\n23rd &amp\; 24th May 2023
 \, Hotel Kohinoor Continental\, Mumbai\, India\n14th Annual Clinical Tria
 ls Summit 20...
UID:6ea1221e-7e33-4d9a-9131-799306a84a64
END:VEVENT
END:VCALENDAR